Joseph A. Pierro
Chief Tech/Sci/R&D Officer at BioMedical Systems Corp.
Profile
Dr. Joseph A.
Pierro, MD, is Independent Director at FluoroPharma Medical, Inc. and Chief Medical Officer at BioMedical Systems Corp.
He is on the Board of Directors at FluoroPharma Medical, Inc.
He received his undergraduate degree from Canisius College and a doctorate degree from New York University.
Joseph A. Pierro active positions
Companies | Position | Start |
---|---|---|
BioMedical Systems Corp.
BioMedical Systems Corp. Medical/Nursing ServicesHealth Services BioMedical Systems Corp. provides centralized diagnostic services to pharmaceutical and medical industries. It offers cardiac modalities, including digital 12-lead electrocardiogram (ECG), TQT/intensive studies, Holter monitoring, ambulatory blood pressure monitoring, and ECG stress testing. The firm also centralizes pulmonary function testing in pharmaceutical and medical device clinical trials for the modalities, including spirometry, peak flow with eDiary, challenge testing, pulse oximetry, nitric oxide, and DLco/lung volumes. The company was founded by W. Raymond Barrett in 1975 and is headquartered in St. Louis, MO. | Chief Tech/Sci/R&D Officer | 2012-06-30 |
Former positions of Joseph A. Pierro
Companies | Position | End |
---|---|---|
FLUOROPHARMA MEDICAL, INC. | Director/Board Member | 2015-11-11 |
Training of Joseph A. Pierro
New York University | Doctorate Degree |
Canisius College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
FLUOROPHARMA MEDICAL, INC. | Commercial Services |
Private companies | 1 |
---|---|
BioMedical Systems Corp.
BioMedical Systems Corp. Medical/Nursing ServicesHealth Services BioMedical Systems Corp. provides centralized diagnostic services to pharmaceutical and medical industries. It offers cardiac modalities, including digital 12-lead electrocardiogram (ECG), TQT/intensive studies, Holter monitoring, ambulatory blood pressure monitoring, and ECG stress testing. The firm also centralizes pulmonary function testing in pharmaceutical and medical device clinical trials for the modalities, including spirometry, peak flow with eDiary, challenge testing, pulse oximetry, nitric oxide, and DLco/lung volumes. The company was founded by W. Raymond Barrett in 1975 and is headquartered in St. Louis, MO. | Health Services |
- Stock Market
- Insiders
- Joseph A. Pierro